Navigation Links
New study evaluates the risk of birth defects among women who take antihistamines in pregnancy
Date:9/16/2013

(Boston) -- Antihistamines are a group of medications that are used to treat various conditions, including allergies and nausea and vomiting. Some antihistamines require a prescription, but most are available over-the-counter (OTC), and both prescription and OTC antihistamines are often used by women during pregnancy. Until recently, little information was available to women and their health care providers on the possible risks and relative safety of these medications in pregnancy, particularly when it came to specific birth defects.

A new study from Boston University's Slone Epidemiology Center, based on interviews with more than 20,000 new mothers, now provides important information for many of these medicines. The researchers considered antihistamines that had been suggested in earlier studies to increase risks of certain defects, and they also considered other possible risks that might not have been identified in the past. Where there was sufficient information in the study data, the authors found no evidence to support suggestions of risk that had been found in earlier studies. In considering possible risks that had not been identified by others, the investigators found very few suggestions that any given medicine might be linked to an increase risk of a specific birth defect, and though these few deserve further research attention, these findings may have been due to chance. The study currently appears in Journal of Allergy and Clinical Immunology: In Practice.

Dr. Allen Mitchell, the study's director, noted that "we were fortunate that our study was able to consider commonly-used antihistamines that were available OTC as well as those available only with a prescription. While our findings provide reassurance about the relative safety of many of these medications in relation to a number of common birth defects, more information is needed. As is the case for all types of medications, women who are pregnant or may become pregnant should consult with their health care provider before taking any medicines, whether they are prescribed or OTC."


'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Hospital study finds connection between dementia, delirium and declining health
2. Cold sore linked to mutation in gene, study suggests
3. New Study Finds Benefits of Combining Blueberries and Exercise
4. Cerebral Palsy and Medical Malpractice Lawsuit Help: Resource4thePeople Reports New Study Narrows Risk Factors
5. Sharp rise in opioid drugs prescribed for non-cancer pain, reports study in Medical Care
6. Pradaxa Bleeding Lawsuits Help: Resource4thePeople Reports another Medical Research Study Finds Increased Bleeding Risks
7. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Comments on New Study Finding that Vaginal Mesh Does Not Improve Pelvic Organ Prolapse Cure Rate
8. NIH clinical study establishes human model of influenza pathogenesis
9. Vaccination with GM2-KLH-QS21 does not improve outcome of melanomas patients in EORTC study
10. Study suggests antioxidant treatment may help NF1-linked behavioral issues
11. New Study Highlights Young People As a Philanthropic Force
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... An August 2 article ... obtaining plastic surgery, largely influenced by the growing popularity of “pretty boys” in both ... notes that standards of male appearance are changing not only in the Asian nation, ...
(Date:8/17/2017)... ... 2017 , ... Pot Valet is a leading provider of premium medical-grade cannabis ... state, and soon, every state in the country, the company offers patients safe, legal, ... altogether. , According to Pot Valet, all California patients have the legal ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... Los Angeles, California (PRWEB) , ... August 16, 2017 , ... An August 3rd ... patients that was the subject of a report in JAMA (the Journal of the American ... (BMIs) above 50 were able to achieve BMIs under 30, when compared to patients with ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second ... England student to educate the public on the impact of concussions. Brooke Mills, ... first-ever National Concussion Awareness Day. , Brooke is working diligently is to raise ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... quarter ended June 30, 2017, and updated its financial ... For the fiscal third quarter, Hill-Rom reported ... per diluted share in the prior-year period. These results ... per diluted share primarily related to the non-cash write-down ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
Breaking Medicine Technology: